P&G Hygiene and Health Care Intrinsic Value
PGHH • Consumer Goods
Current Stock Price
₹9323.00
Primary Intrinsic Value
₹6620.00
Market Cap
₹307.7K Cr
-60.0%
Downside
Median Value
₹3729.20
Value Range
₹1865 - ₹6620
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
PGHH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹6620.00 | ₹5296.00 - ₹7944.00 | -29.0% | EPS: ₹264.80, Sector P/E: 25x |
| Book Value Method | asset | ₹1864.60 | ₹1678.14 - ₹2051.06 | -80.0% | Book Value/Share: ₹223.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2796.90 | ₹2517.21 - ₹3076.59 | -70.0% | Revenue/Share: ₹1330.30, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹4407.27 | ₹3966.54 - ₹4848.00 | -52.7% | EBITDA: ₹1212.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹3729.20 | ₹2983.36 - ₹4475.04 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2796.90 | ₹2517.21 - ₹3076.59 | -70.0% | EPS Growth: 10.5%, Fair P/E: 8.4x |
| Growth Adjusted P/E | growth | ₹4834.05 | ₹4350.65 - ₹5317.46 | -48.1% | Revenue Growth: 2.8%, Adj P/E: 18.3x |
| ROE Based Valuation | profitability | ₹4661.50 | ₹4195.35 - ₹5127.65 | -50.0% | ROE: 116.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2796.90 | ₹2517.21 - ₹3076.59 | -70.0% | EPS: ₹264.80, BVPS: ₹223.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
PGHH Intrinsic Value Analysis
What is the intrinsic value of PGHH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of P&G Hygiene and Health Care (PGHH) is ₹3729.20 (median value). With the current market price of ₹9323.00, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹1864.60 to ₹6620.00, indicating ₹1864.60 - ₹6620.00.
Is PGHH undervalued or overvalued?
Based on our multi-method analysis, P&G Hygiene and Health Care (PGHH) appears to be trading above calculated value by approximately 60.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.32 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 116.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 26.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.50x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for P&G Hygiene and Health Care
Additional stock information and data for PGHH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹593 Cr | ₹576 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹470 Cr | ₹470 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹826 Cr | ₹821 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹573 Cr | ₹560 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹863 Cr | ₹863 Cr | Positive Free Cash Flow | 8/10 |